Infection in Kidney Transplantation

Infection is an important cause of morbidity and mortality after kidney transplantation. It has been estimated that 70% of kidney transplant recipients will experience an infection episode within the first 3 years after transplantation (Dharnidharka et al. 2007). After cardiovascular disease, infection is the second leading cause of death in recipients with allograft function (Snyder et al. 2009). The immunosuppressive therapy required to prevent organ rejection places the kidney transplant recipient at increased risk for donor-derived, nosocomial, and community-acquired infections as well as reactivation of latent pathogens. Pretransplant screening, immunizations, and optimal antibacterial and antiviral prophylaxis can help to reduce the impact of infection. Awareness of the approach to infection in the transplant recipient including diagnostic and management strategies is essential to optimizing outcomes.

• Publication year

  2018

• Venue

  Contemporary Kidney Transplantation

• Publication date

  2018-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-19617-6_22PMCID 7123753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Principles and Practice of Transplant Infectious Diseases

  2019influential reference
• Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct‐Acting Antiviral Agents

  2016cited by this paper
• Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2015cited by this paper
• HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years.

  2015cited by this paper
• Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management

  2015cited by this paper
• Should we treat asymptomatic bacteriuria after renal transplantation?

  2014cited by this paper
• Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

  2014cited by this paper
• Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

  2014cited by this paper
• Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.

  2014cited by this paper
• Allowing HIV‐Positive Organ Donation: Ethical, Legal and Operational Considerations

  2013cited by this paper
• Pneumocystis Pneumonia in Solid Organ Transplantation

  2013cited by this paper
• Screening of Donor and Recipient in Solid Organ Transplantation

  2013cited by this paper
• PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Transmission through Organ Transplantation

  2013cited by this paper
• Viral Hepatitis in Solid Organ Transplantation

  2013cited by this paper
• Common infections in kidney transplant recipients.

  2012influential reference
• Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients

  2012cited by this paper
• Human cytomegalovirus and kidney transplantation: a clinician's update.

  2011influential reference
• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cited by this paper
• HIV transmitted from a living organ donor--New York City, 2009.

  2011cited by this paper
• 薬疹up to date

  2011cited by this paper
• Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder

  2010cited by this paper
• Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

  2010cited by this paper
• Renal transplantation in patients with hepatitis C virus antibody. A long national experience

  2010cited by this paper
• The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

  2010cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

  2010cited by this paper
• Outcomes of kidney transplantation in HIV-infected recipients.

  2010influential reference
• Renal transplantation in patients with HIV

  2009cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009influential reference
• Rates of first infection following kidney transplant in the United States.

  2009cited by this paper
• Epstein‐Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

  2009cited by this paper
• Transplantation in the patient with hepatitis C

  2009cited by this paper
• Cytomegalovirus in Solid Organ Transplant Recipients

  2009cited by this paper
• Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

  2009cited by this paper
• Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial.

  2008cited by this paper
• Incisional surgical site infection in kidney transplantation.

  2008cited by this paper
• BK virus nephritis after renal transplantation.

  2008influential reference
• Epidemiology of BK Virus in Renal Allograft Recipients: Independent Risk Factors for BK Virus Replication

  2008cited by this paper
• Viral infection after renal transplantation: surveillance and management.

  2008influential reference
• Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation.

  2008cited by this paper
• Prevention and management of cytomegalovirus infection in solid-organ transplantation

  2007cited by this paper
• Infection in solid-organ transplant recipients.

  2007cited by this paper
• Vaccination and chronic kidney disease.

  2007cited by this paper
• Risk Factors for Hospitalization for Bacterial or Viral Infection in Renal Transplant Recipients—An Analysis of USRDS Data

  2007influential reference
• Effects of immunosuppressive drugs on HIV infection: implications for solid‐organ transplantation

  2007cited by this paper
• Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft.

  2007cited by this paper
• Recommended Adult Immunization Schedule: United States, October 2007September 2008*

  2007cited by this paper
• Transmission of lymphocytic choriomeningitis virus by organ transplantation.

  2006cited by this paper
• 24-Week Oral Ganciclovir Prophylaxis in Kidney Recipients Is Associated with Reduced Symptomatic Cytomegalovirus Disease Compared to a 12-Week Course

  2006cited by this paper
• BK Virus Infection in Transplant Recipients: An Overview and Update

  2006cited by this paper
• Viral Infections Affecting the Skin in Organ Transplant Recipients

  2006cited by this paper
• Adenovirus infections in transplant recipients.

  2006cited by this paper
• Thymoglobulin‐Associated Cd4+ T‐Cell Depletion and Infection Risk in HIV‐Infected Renal Transplant Recipients

  2006cited by this paper
• Polyomavirus‐associated nephropathy: update on antiviral strategies

  2006cited by this paper
• Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients

  2006cited by this paper
• Transmission of rabies virus from an organ donor to four transplant recipients.

  2005cited by this paper
• Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

  2005cited by this paper
• HBsAg Seropositive Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies

  2005cited by this paper
• Viral infection in the renal transplant recipient.

  2005cited by this paper
• Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations

  2005cited by this paper
• Infectious complications in kidney transplant recipients: review of the literature.

  2005influential reference
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Prognosis of HTLV-I-positive renal transplant recipients.

  2005cited by this paper
• Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods.

  2005cited by this paper
• Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

  2005cited by this paper
• Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

  2004cited by this paper
• The Value of Vaccination in Chronic Kidney Disease

  2004cited by this paper
• Vital Role of Medical Examiners and Coroners in Organ Transplantation

  2004cited by this paper
• Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation

  2004cited by this paper
• Solid organ transplantation in the HIV‐infected patient

  2004cited by this paper
• Polyoma Nephropathy and Progressive Multifocal Leukoencephalopathy in a Renal Transplant Recipient

  2004cited by this paper
• Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival.

  2004cited by this paper
• Infections in Solid Organ Transplant Patients

  2004influential reference
• Guidelines for the prevention and management of infectious complications of solid organ transplantation

  2004influential reference
• Polyomavirus in kidney and kidney‐‐pancreas transplant recipients

  2003cited by this paper
• Fatal disseminated adenovirus infections in immunocompromised patients.

  2003cited by this paper
• Fungal Infections in Solid Organ Transplant Patients

  2003cited by this paper
• Preemptive lamivudine therapy based on HBV DNA level in HBsAg‐positive kidney allograft recipients

  2002cited by this paper
• The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation1, 2

  2002cited by this paper
• Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature.

  2002cited by this paper
• Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection.

  2002cited by this paper
• Hospitalizations for Bacterial Septicemia after Renal Transplantation in the United States

  2001cited by this paper
• Human herpesvirus‐6 and ‐7 in transplantation

  2001cited by this paper
• Cytomegalovirus in renal transplantation.

  2001cited by this paper
• ARE WOUND COMPLICATIONS AFTER A KIDNEY TRANSPLANT MORE COMMON WITH MODERN IMMUNOSUPPRESSION?

  2001cited by this paper
• HHV8 in renal transplant recipients

  2000cited by this paper
• Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

  2000influential reference
• Co‐infection of two β‐herpesviruses (CMV and HHV‐7) as an increased risk factor for ‘CMV disease’ in patients undergoing renal transplantation

  2000cited by this paper
• Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

  2000influential reference
• Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.

  2000cited by this paper
• Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients.

  1998cited by this paper
• CMV infection is associated with transplant renal artery stenosis.

  1998cited by this paper
• Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients.

  1998cited by this paper
• Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.

  1997cited by this paper
• Infections in solid-organ transplant recipients

  1997influential reference
• Human Herpesvirus-6 in Transplantation: An Emerging Pathogen

  1996cited by this paper
• The evaluation and management of urinary tract infections in recipients of solid-organ transplants.

  1994cited by this paper
• The evaluation and management of urinary tract infections in recipients of solid-organ transplants.

  1994cited by this paper
• Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine.

  1993cited by this paper
• POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTS: CLINICAL EXPERIENCE AND RISK FACTOR ANALYSIS IN A SINGLE CENTER

  1993cited by this paper
• Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: a matched-pair case-control study.

  1992cited by this paper

• Infectious Diarrhea in Kidney Transplant Recipients

  2025cites this paper
• Incidence, Risk Factors and Outcomes of Urinary Tract Infections in Renal Transplant Recipients – Prospective Observational Study

  2025cites this paper
• Incidence and risk factors of infections following kidney transplantation.

  2024cites this paper
• Do not forget about transplant patients during disasters

  2024cites this paper
• Pneumonia in Transplant Recipients: A Comprehensive Review of Diagnosis and Management

  2024cites this paper
• Antituberculosis Therapy-Induced Acute Liver Failure in a Renal Transplant Recipient: A Case Report

  2024cites this paper
• Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications

  2023cites this paper
• Lower levels of FOXP3 are associated with prolonged inflammatory responses in kidney transplant recipients

  2023cites this paper
• Spectrum of infections in kidney transplant recipients: A single centre retrospective cohort study

  2023cites this paper
• An unusual case of late, isolated involvement of renal allograft with tuberculosis

  2023cites this paper
• A plant pathogen in a human host! A case report and a review of literature

  2023cites this paper